JOHN E. KAO - 12 Jan 2026 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Issuer symbol
ALHC
Transactions as of
12 Jan 2026
Net transactions value
-$3,799,219
Form type
4
Filing time
14 Jan 2026, 16:28:00 UTC
Previous filing
30 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KAO JOHN E Chief Executive Officer, Director 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao 14 Jan 2026 0001222028

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALHC Common Stock Sale $3,740,407 -177,273 -5.9% $21.10 2,835,368 12 Jan 2026 See Footnote F1, F2, F3, F4
transaction ALHC Common Stock Sale $58,812 -2,727 -0.1% $21.57 2,832,641 12 Jan 2026 See Footnote F1, F3, F4, F5
holding ALHC Common Stock 1,568,379 12 Jan 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Date of Rule 10b5-1 plan adoption: 03/12/2025
F2 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.48 to $21.47. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3 Balances in column 5 reflect the transfer on 01/08/2026 of 665,915 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
F4 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
F5 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.48 to $21.67. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.